Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Director/PDMR Shareholding

27 Sep 2017 16:59

RNS Number : 0162S
Cello Group plc
27 September 2017
 

27 September 2017

Cello Group plc

 ("Cello" or the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to transfer the Ordinary Shares to Mr Bentley's SIPP. The sale price was 127.50 pence per share and the purchase price was 127.53 pence per share.

The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Bentley and, following this transaction, Mr Bentley remains beneficially and non-beneficially interested in 442,518 Ordinary Shares, representing approximately 0.4 per cent. of the Company's issued ordinary share capital.

The Company has also received notification that on 27 September 2017, Jane Shirley, a director of Cello Health, exercised share options over 20,000 Ordinary Shares for an exercise price of 10 pence per share, and subsequently sold the 20,000 Ordinary Shares for a price of 127 pence per share. In addition, on 26 September 2017, Alistair Shirley, a person closely associated with Jane Shirley, sold 421 Ordinary Shares at a price of 129 pence per share.

Following the above transactions, Jane Shirley and her persons closely associated hold 78,000 Ordinary Shares, representing approximately 0.1% of the Company's issued ordinary share capital.

 

Enquiries:

 

Cello Group

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Cenkos Securities

0207 397 8900

Bobbie Hilliam

Harry Hargreaves

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.50p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,250

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.53p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,283

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

10p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£2,000

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

Outside trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£25,400

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Alistair Shirley

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

129p

421

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

421

 

£543.09

e)

Date of the transaction

26 September 2017

f)

Place of the transaction

XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBVVRBWAKUAR
Date   Source Headline
29th Jun 20077:01 amRNSDirector/PDMR Shareholding
28th Jun 20077:01 amRNSDirectorate Change
8th Jun 20077:01 amRNSAcquisition
22nd May 20071:00 pmRNSAGM Statement
16th May 20079:43 amRNSShare Option Grants
1st May 20074:15 pmRNSAnnual Report and Accounts
1st May 20074:13 pmRNSShare Option Grants
27th Apr 200712:41 pmRNSDirector/PDMR Shareholding
26th Apr 20077:01 amRNSInvestment
10th Apr 20079:44 amRNSTotal voting rights update
2nd Apr 20073:48 pmRNSDirector/PDMR Shareholding
30th Mar 20077:01 amRNSAcquisition
29th Mar 20072:07 pmRNSHolding(s) in Company
20th Mar 20077:01 amRNSFinal Results
9th Mar 20071:18 pmRNSHolding(s) in Company
28th Feb 20074:53 pmRNSHolding(s) in Company
19th Feb 200711:14 amRNSNotice of Results
2nd Feb 20073:05 pmRNSTotal Voting Rights
29th Jan 20077:01 amRNSAcquisition
19th Jan 20073:19 pmRNSHolding(s) in Company
11th Jan 20077:01 amRNSPre Close Trading Statement
15th Dec 20069:01 amRNSDirector/PDMR Shareholding
12th Dec 20069:00 amRNSTotal Voting Rights
30th Nov 20063:56 pmRNSHolding(s) in Company
13th Nov 200612:48 pmRNSAnalyst/Investor Presentation
5th Oct 20065:10 pmRNSNotifiable Interest
4th Oct 20063:53 pmRNSHolding(s) in Company
26th Sep 20067:03 amRNSAcquisition
11th Sep 20063:58 pmRNSHolding(s) in Company
5th Sep 20067:02 amRNSInvestment in Digital Agency
5th Sep 20067:02 amRNSInterim Results
17th Aug 20069:54 amRNSNotice of Results
26th Jul 20062:17 pmRNSAdditional Listing
3rd Jul 200611:53 amRNSAdditional Listing
3rd Jul 20067:01 amRNSPre Close Trading Statement
3rd Jul 20067:01 amRNSControlling Stake
26th Jun 20063:23 pmRNSInvest in brand consulting op
26th Jun 20067:19 amRNSAcquisition
21st Jun 200612:15 pmRNSAnnual Report and Accounts
19th Jun 20063:22 pmRNSMajor Interest in Shares
23rd May 200612:58 pmRNSAGM Statement
27th Mar 20065:46 pmRNSMajor Interest in Shares
27th Mar 20065:05 pmRNSMajor Interests in Shares
21st Mar 20063:39 pmRNSHolding(s) in Company
16th Mar 20067:00 amRNSPerformance Share Option Plan
15th Mar 20067:01 amRNSDirector/PDMR Shareholding
14th Mar 20067:05 amRNSShare Option Plan
14th Mar 20067:02 amRNSFinal Results
20th Feb 20065:19 pmRNSNotice of Results
25th Jan 20063:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.